Participate in Quizzes daily and WIN POINTS!

Quiz on Congenital Cytomegalovirus Causes, Symptoms, and Treatment

Dear doctors participate in this fun and exciting quiz on Congenital cytomegalovirus. Congenital cytomegalovirus (CMV) infection occurs when the virus is passed from mother to baby during pregnancy, potentially leading to hearing loss, vision problems, and developmental delays in infants. Discovered in the 1950s, CMV is now managed with antivirals like ganciclovir for symptomatic cases, while preventive measures are emphasized. Participate Now.

1. Which of the following is the most common clinical manifestation of congenital CMV infection in infants?

2. What is the primary method for diagnosing congenital CMV infection in an infant?

3. In which scenario is antiviral therapy for congenital CMV most strongly recommended?

4. Which of the following antiviral agents is most commonly used to treat symptomatic congenital CMV infection?

5. Which of the following strategies is recommended for preventing congenital CMV infection in pregnant women?

Recommended Quizzes

Quiz On Pediatric Dental Care


Quiz on Pediatric Speech Therapy


Quiz On Febrile Seizure Management


Quiz on Pediatric Interventional Bronchoscopy


Quiz On Meningitis Management


Quiz On Hepatitis Management


Quiz on Pediatric Dermatology: Diagnosing and Managing Eczema, Psoriasis, and Other Skin Disorders


Quiz On Antibiotic Resistance


Quiz On General Pediatric Care


Quiz On Pediatrics Long Term Diseases


Quiz On Pediatric Vaccine


Quiz on Ocular Blood Flow in Preterm Neonates


Quiz On Wilms Tumor Management


Quiz On Neonatal Jaundice Prevention


Quiz on Shaken Baby Syndrome Causes, Symptoms, and Prevention


Quiz On Child Obesity


Quiz on Craniosynostosis Management


Quiz on Pediatric Rare Diseases


Quiz On Childhood Asthma


Quiz On Rotavirus Management



Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes


Whats more on Hidoc Dr.


Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Participate and win exciting prizes

Participate and win cash vouchers

Get updates on the latest events happening around the world


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot